Abstract

The biopharmaceutical industry has a growing demand and an increasing need to improve the current virus purification technologies, especially as more and more vaccines are produced from cell-culture derived virus particles. Downstream purification strategies can be expensive and account for 70% of the overall manufacturing costs. The economic pressure and… (More)

Topics

72 Figures and Tables

Cite this paper

@inproceedings{Vijayaragavan2015VirusPD, title={Virus purification, detection and removal}, author={Khrupa Saagar Vijayaragavan and Caryn L. Heldt and Adrienne R Minerick and Megan C. Frost and Timothy C. Eisele and Subhashree Vijayaragavan}, year={2015} }